Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies
Objectives: Serum autoantibodies are pivotal for the early detection of systemic autoimmune rheumatic diseases such as Systemic Sclerosis (SSc) and Poly/Dermatomyositis (PM/DM), and in some cases are associated with organ complications such as interstitial lung disease (ILD). A paradigmatic example...
Main Authors: | Angela Ceribelli, Natasa Isailovic, Maria De Santis, Carolina Gorlino, Minoru Satoh, Carlo Selmi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Journal of Translational Autoimmunity |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589909020300162 |
Similar Items
-
Idiopathic Inflammatory Myopathies; Association with Overlap Myositis and Syndromes: Classification, Clinical Characteristics, and Associated Autoantibodies
by: Pari Basharat
Published: (2016-07-01) -
The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases
by: Minoru eSatoh, et al.
Published: (2015-04-01) -
Management of Myositis-Associated Interstitial Lung Disease
by: Tomoyuki Fujisawa
Published: (2021-04-01) -
Autoantibodies in Myositis. How to Achieve a Comprehensive Strategy for Serological Testing
by: Miriam Mende, et al.
Published: (2019-01-01) -
The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01)